2024-07-05
Share：
Driven by the wave of digitalization, artificial intelligence technology is becoming a pioneering force representing new productive forces, reshaping the medical industry with unprecedented speed and depth. Recently, the 2024 (6th) Innovation Development Forum, co-hosted by the Chinese Academy of Sciences "Internet Weekly", the Information Research Center of the Chinese Academy of Social Sciences, eNet Research Institute, and Deben Consulting, was successfully held. During the event, the highly anticipated "Golden i Award" winners were announced. As a leading enterprise in domestic medical big data and artificial intelligence, DHC was honored with the "2024 Medical Big Model Science Excellence Award" for its exceptional performance in AI technology innovation and application in the medical industry. This award not only highly recognizes the technical strength of DHC but also fully affirms its leadership position in the industry.
As one of the most attention-grabbing science and technology awards in China, the "Golden i Award" strives to select those enterprises with vitality and innovative genes from the new technology industry in China on multiple levels, dimensions, and specializations. It aims to unearth the core forces in the process of scientific innovation, consistently focusing on various industries, exploring the power of China's new technology, and providing strategic advice and supportive references for relevant government functions, economic regions, industrial parks, and policy departments of industry, education, and research. After several rounds of selection and incorporating opinions from professional analysts, the official list of "Golden i Award" winners was released.
As a "world-class, domestically leading" enterprise in medical big data and artificial intelligence, DHC has been responsible for constructing and maintaining several national specialized disease data platforms since 2016, including the National Cancer Big Data Center, the National Cardiovascular Big Data Platform, the China Rare Disease Registry System, the China Kidney Disease Big Data Platform, and the Health Commission's National COVID-19 Database.
With the advent of the big model era, DHC relies on its platform's high-quality, massive medical data and insists on independent technological innovation. It has not only formed a complete closed loop from data integration and governance to analysis but also trained large models supporting multimodal medical applications through deep learning and artificial intelligence technologies. These efforts significantly enhance the application capabilities of big models in the medical field, becoming an important force in promoting the high-quality development of medical health.
Technology Leads
The Core Power of Innovation-Driven AI
The technological advantage of DHC's big model is the cornerstone of its leading position in the medical AI field. Relying on rapid progress in deep learning technology and continuous accumulation of high-quality medical data, DHC's big model independently develops a multimodal big model integrated with text, imaging, pathology, and precision medicine modalities for the medical vertical domain.
By deeply managing clinical data, imaging data, pathological data, and genetic data, DHC's big model enables comprehensive empowerment in various scenarios such as clinical diagnosis and treatment, intelligent scientific research, health management, hospital operations, and intelligent disease control. Not only does it possess powerful data processing capabilities that can turn vast medical data into valuable data assets for providing deep insights for medical decision-making and intelligent engines for medical research, but it also promotes the innovation and optimization of medical services on multiple levels. Moreover, DHC's industry-leading multimodal AI capabilities demonstrate significant reasoning and generation abilities in precise diagnosis and treatment of specialties and diseases, effectively enhancing diagnostic efficiency and accuracy.
Value First
A Practical Example of Clinical Transformation and Precise Diagnosis and Treatment
Application value is a key indicator to measure the advantages of vertical domain big models. The application value advantage of DHC's big model is reflected in its comprehensive improvement of medical service quality and significant enhancement of medical efficiency. Through cooperation with Southern Hospital of Southern Medical University, DHC established the first domestic large model-assisted comprehensive multimodal data governance system for the entire hospital. This system not only unifies the hospital's data management but also greatly improves data utilization efficiency and diagnostic precision. Additionally, DHC supports Chongqing University Cancer Hospital in building the first domestic large model-supported intelligent oncology knowledge base, providing strong knowledge support for oncology research and clinical treatment.
In clinical department applications, DHC's big model utilizes big data, artificial intelligence, and multimodal integration technology to integrate different modal data such as structural data, medical text, electrophysiological signals, medical imaging, digital pathology, and genomics. Combined with multimodal clinical decision support technology and authoritative medical knowledge bases, it offers full-chain, one-stop intelligent data processing and clinical decision-making capabilities. This provides doctors with intelligent decision support services based on multimodal data fusion algorithms in diagnosis, treatment, prognosis, and other clinical aspects, significantly improving doctors' work efficiency, diagnostic accuracy, medical service quality, reducing medical costs, enhancing patient satisfaction, boosting hospital specialty capabilities, forming a practical example of medical industry digital transformation.
International Recognition
Chinese Wisdom on the Global Stage
The outstanding performance of DHC's big model on the international stage highlights its international reputation and influence in the medical AI field. At the recent global rare disease big model AI technology competition held at GitHub headquarters in San Francisco, DHC joined top teams including Peking Union Medical College Hospital to compete against international rivals in technology and wisdom. With an excellent big model performance, they achieved one of the top three positions worldwide. This achievement not only showcases DHC's innovative strength in medical big data and artificial intelligence but also reflects the outstanding competitiveness of DHC's big model in the international medical AI field.
Based on the application of DHC's big model technology, DHC collaborates with well-known academic institutions and experts at home and abroad to achieve fruitful scientific research results in multiple diseases and fields such as cancer, rare diseases, kidney diseases, COVID-19, precision medicine, and privacy protection. Articles have been published in high-level international academic journals like BMJ, The Lancet Regional Health, Nature Genetics, contributing Chinese wisdom and solutions to the global healthcare cause.
TOP
